These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36082093)
21. Successful neoadjuvant therapy with trastuzumab, paclitaxel and epirubicin for an elderly patient with inflammatory breast cancer. Shimizu T; Hirano A; Watanabe O; Kinoshita J; Kimura K; Kamimura M; Domoto K; Kim N; Ogawa K; Fujibayashi M Anticancer Res; 2010 Feb; 30(2):581-5. PubMed ID: 20332474 [TBL] [Abstract][Full Text] [Related]
22. [A Case of Sentinel Lymph Node Biopsy for Male Breast Cancer]. Yamasaki Y; Yamasaki Y; Tsuboi J Gan To Kagaku Ryoho; 2016 Nov; 43(12):2429-2431. PubMed ID: 28133344 [TBL] [Abstract][Full Text] [Related]
23. Retrospective analysis of neoadjuvant chemotherapy for breast cancer in Turkish patients. Duman BB; Afşar ÇU; Günaldi M; Sahin B; Kara IO; Erkisi M; Erçolak V Asian Pac J Cancer Prev; 2012; 13(8):4119-23. PubMed ID: 23098527 [TBL] [Abstract][Full Text] [Related]
24. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization. Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228 [TBL] [Abstract][Full Text] [Related]
25. Local recurrence of mammary Paget's disease after nipple-sparing mastectomy and implant breast reconstruction: a case report and literature review. Pu Q; Zhao Q; Gao D World J Surg Oncol; 2022 Sep; 20(1):285. PubMed ID: 36064544 [TBL] [Abstract][Full Text] [Related]
26. [Treatment Regimens for Breast Cancer in Elderly Patients in Whom the Diagnosis Was Switched from Malignant Phyllodes Tumor to Spindle-Cell Carcinoma after Surgery]. Hayashi K; Waraya M; Habiro T; Ishii K; Inukai M; Kojima K; Sengoku N; Sangai T Gan To Kagaku Ryoho; 2020 Dec; 47(13):2047-2049. PubMed ID: 33468796 [TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis. Medical Advisory Secretariat Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401 [TBL] [Abstract][Full Text] [Related]
28. [Complete response of advanced breast cancer with lymph node metastases to nab-paclitaxel therapy-report of a case]. Hara Y; Sakurai K; Enomoto K; Matsumoto K; Ueda Y; Hagiwara M; Waga E; Nagashima S; Tani M; Amano S Gan To Kagaku Ryoho; 2012 Nov; 39(12):2080-2. PubMed ID: 23267983 [TBL] [Abstract][Full Text] [Related]
29. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer]. Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072 [TBL] [Abstract][Full Text] [Related]
30. [Sentinel lymph node biopsy in male breast cancer - a case report]. Nishi T; Nishimura A; Morohashi S; Hakamada K Gan To Kagaku Ryoho; 2014 Nov; 41(12):1972-4. PubMed ID: 25731393 [TBL] [Abstract][Full Text] [Related]
31. Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast. von Minckwitz G; Sinn HP; Raab G; Loibl S; Blohmer JU; Eidtmann H; Hilfrich J; Merkle E; Jackisch C; Costa SD; Caputo A; Kaufmann M; Breast Cancer Res; 2008; 10(2):R30. PubMed ID: 18380893 [TBL] [Abstract][Full Text] [Related]
32. Breast carcinoma with spontaneous regression after needle biopsy: a case report and literature review. Sasamoto M; Yamada A; Oshi M; Ota I; Yoshida K; Yakeishi M; Tsuura Y; Masui H; Endo I Gland Surg; 2023 Jun; 12(6):853-859. PubMed ID: 37441009 [TBL] [Abstract][Full Text] [Related]
33. A case of HER-2-positive advanced inflammatory breast cancer with invasive micropapillary component showing a clinically complete response to concurrent trastuzumab and paclitaxel treatment. Shigematsu H; Nakamura Y; Tanaka K; Shiotani S; Koga C; Kawaguchi H; Nishimura S; Taguchi K; Nishiyama K; Ohno S Int J Clin Oncol; 2010 Dec; 15(6):615-20. PubMed ID: 20473628 [TBL] [Abstract][Full Text] [Related]
34. [A Case of Duplicated Cancer Simultaneously Causing Breast and Endometrial Cancer]. Kubota H; Suzuki Y; Adachi K; Suzuki S; Hara Y; Fujisaki S; Makishima M; Saga R; Hirano T; Sakurai K Gan To Kagaku Ryoho; 2019 Feb; 46(2):339-341. PubMed ID: 30914553 [TBL] [Abstract][Full Text] [Related]
35. Marked lymphovascular invasion, progesterone receptor negativity, and high Ki67 labeling index predict poor outcome in breast cancer patients treated with endocrine therapy alone. Kurebayashi J; Kanomata N; Shimo T; Yamashita T; Aogi K; Nishimura R; Shimizu C; Tsuda H; Moriya T; Sonoo H Breast Cancer; 2014 Mar; 21(2):214-22. PubMed ID: 22689016 [TBL] [Abstract][Full Text] [Related]
36. [A long-term survival case of local recurrence of breast cancer treated with combined modality therapy]. Katsuta E; Ohkubo T; Someno Y; Saguchi M; Aoyagi H; Takahata T; Hasegawa K; Hamada S; Kaneko J; Maejima S Gan To Kagaku Ryoho; 2010 Nov; 37(12):2760-2. PubMed ID: 21224704 [TBL] [Abstract][Full Text] [Related]
37. Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial. Martin M; Brase JC; Calvo L; Krappmann K; Ruiz-Borrego M; Fisch K; Ruiz A; Weber KE; Munarriz B; Petry C; Rodriguez CA; Kronenwett R; Crespo C; Alba E; Carrasco E; Casas M; Caballero R; Rodriguez-Lescure A Breast Cancer Res; 2014 Apr; 16(2):R38. PubMed ID: 24725534 [TBL] [Abstract][Full Text] [Related]
38. Esophageal metastasis of breast cancer during endocrine therapy for pleural dissemination 21 years after breast surgery: a case report. Miyake M; Yamada A; Miyake K; Endo I Surg Case Rep; 2019 Feb; 5(1):22. PubMed ID: 30771195 [TBL] [Abstract][Full Text] [Related]
39. Male triple negative axillary accessory breast cancer-a case report. Li C; Qian B Transl Cancer Res; 2022 Aug; 11(8):2926-2930. PubMed ID: 36093543 [TBL] [Abstract][Full Text] [Related]
40. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma. Tsutsumi Y Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]